Rocket Lab (RKLB) Shed Nearly $10 Billion in Seven Sessions…

Rocket Lab (NASDAQ: RKLB) fell for seven straight trading days into August 27, a 19.4% slide that erased roughly $10 billion of market value and cut its valuation to about $40 billion. What makes the move stand out is what the rest of the market did over the same stretch: almost nothing. The S&P 500 slipped just 0.9%, so this was a company-specific repricing, not a market selloff dragging a high-beta name down with it.

The slide has also, for now, stopped. RKLB turned higher on August 28, up about 2%, so the story is no longer a stock in free fall but a sharp, sector-driven derating that has stabilized, and the question of what the market was actually pricing in.

What Happened: ~19% and ~$10 Billion Gone While the Index Barely Moved

The decline was steady rather than a single shock. Trefis tracked it session by session, from a 17% cumulative loss at five days to 18% at six and 19.4% at seven days through August 27, against the S&P 500’s 0.9% over the same window. On August 27 the stock traded between $65.42 and $67.68 before the next session’s bounce.

When a single stock loses a fifth of its value while the index it sits in barely moves, the selling is about that company, not the market, and here it points to what investors are willing to pay for growth that still burns cash. Rocket Lab has never turned a profit, and in a tape defined by rising long-term yields and a rotation out of speculative names, the market marks that kind of business down first. The decoupling is evidence that sentiment toward unprofitable, high-multiple stocks shifted, and Rocket Lab is one of the purest expressions of that trade.

Investor Takeaway

The Record Quarter That Did Not Hold the Stock

The RKLB slide came weeks after the Space company posted a record quarter. Rocket Lab reported Q2 revenue of $234.07 million, up 62% year over year and above the $230.94 million consensus, with backlog surging 137% to a record $2.36 billion and a launch backlog exceeding 90 missions. Adjusted EBITDA loss of $8.8 million came in far better than the guided $20 million to $26 million, and non-GAAP gross margin of 41.5% topped guidance.

The net loss of $0.08 per share was wider than the $0.05 analysts expected, and on a trailing basis Rocket Lab has produced $769.1 million of revenue against a $165.5 million net loss. For a company still scaling toward its first Neutron launch, that combination of fast growth and persistent cash burn is exactly what a higher-rate, risk-off tape punishes, which is why a record quarter and a record backlog were not enough to hold the stock.

Neutron and Iridium: What the Bull Case Is Waiting On

The bull case rests on things that have not happened yet. Neutron, the medium-lift rocket meant to move Rocket Lab from a small-launch niche into the heart of the commercial and government market, is targeted for the pad in the fourth quarter of 2026, though CEO Peter Beck cautioned that the window for an end-of-year launch “is narrowing.” The company is also pursuing an acquisition of Iridium Communications, whose future capacity needs Beck cited as one claim on Neutron’s limited early flights.

In the meantime, the contract pipeline is real. Rocket Lab won roughly $663 million in US Space Force awards over an eight-day span in late July, including a record $266 million launch deal and a $397 million award to build threat-tracking satellites for launch on Neutron. So the market is not doubting demand. It is waiting to see execution on Neutron before it pays up again, and until then the stock trades on sentiment and rates.

The Form 144 and Why It Isn’t the Signal It Looks Like

One detail that circulated during the slide was an insider filing, and it needs context rather than alarm. Chief Operations Officer Frank Klein filed a Form 144 on August 27 signaling intent to sell 35,558 shares, an indicated value of about $2.35 million. A Form 144 is a notice of a proposed sale, not a completed one, and the mechanics defuse the “insiders selling the dip” read: the related sales were executed under a Rule 10b5-1 plan to cover tax withholding on vesting restricted stock, per Rocket Lab’s SEC filings.

Klein still directly holds 961,295 shares, worth about $66 million, and the filing is one in an ongoing series of scheduled RSU-related sales rather than a slide-timed bet against the company. It is a footnote to the selloff, not its cause.

What Ended the Slide, and What the Sector Is Doing

To understand both the fall and the bounce, you have to zoom out to the sector. Rocket Lab peaked near $151 in May, then got swept into a brutal rotation after SpaceX’s June IPO, as investors sold public space names to fund the new giant. Over one month this summer, Rocket Lab fell about 36%, with peers Planet Labs, AST SpaceMobile, and Intuitive Machines down 34% to 43% despite strong results, before the group roared back 28% to 54% in early August. FinanceFeeds mapped that whiplash in the SpaceX effect and the space-stock reversal.

This latest seven-day leg down came as an AI-hardware selloff and rising long-term yields pressured high-multiple growth names across the board.

So while Rocket Lab decoupled from the S&P, it moved with its own sector, and the August 28 turn coincided with that group finding a bid. At about $67, the stock now sits below the $76 base case in the FinanceFeeds RKLB $104 bull, $76 base, $41 bear breakdown, which frames how much of the Neutron optionality the market has priced out.

Investor Takeaway